Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
W. Mike Heath ASHP Federal Forum Posters
Home
W. Mike Heath ASHP Federal Forum Posters
All Days
Sun, Dec 3
W. Mike Heath ASHP Federal Forum Posters
Type here to filter the list
Sunday, December 3, 2023
3:30 PM – 5:00 PM
(1-001) A Quantitative Study of the Causes of Drug Shortages in Saudi Arabia: A Healthcare Professionals Perspective and Views
Favorite
3:30 PM – 5:00 PM
(1-002) Pharmacist-Managed Inhaled Corticosteroid De-Escalation in Patients with Stable COPD at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-003) Evaluation of Methotrexate Prescribing Practices in a Veterans Affairs Health Care System
Favorite
3:30 PM – 5:00 PM
(1-004) Impact of an Addition of a Clinical Pharmacist to a Weight Management Clinic at a Military Treatment
Favorite
3:30 PM – 5:00 PM
(1-005) Coronary Endoprothesis: State of Play and Prescription Critical Analysis at a University Hospital
Favorite
3:30 PM – 5:00 PM
(1-006) Elaboration of a Good Practice Guide for the Administration of Parenteral Antibiotics at a University Hospital
Favorite
3:30 PM – 5:00 PM
(1-007) Lipid-Lowering Medication Adherence in American Indians with Type 2 Diabetes: A Multi-Year Picture
Favorite
3:30 PM – 5:00 PM
(1-008) Implementation of a Low-Barrier Model for Treatment of Opioid Use Disorder with a Pharmacist Driven Coordination Team
Favorite
3:30 PM – 5:00 PM
(1-009) Development of an Ambulatory Care Clinical Pharmacist Job-Share
Favorite
3:30 PM – 5:00 PM
(1-010) Potential Solutions to Assist with Pharmacy Technician Shortage in Community Practice Operations
Favorite
3:30 PM – 5:00 PM
(1-011) Propofol Related Infusion Syndrome Typical Presentation with Hyperpyrexia: Case Report
Favorite
3:30 PM – 5:00 PM
(1-012) Medication Use Evaluation of Dopamine Agonists for the Treatment of Restless Leg Syndrome in a Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-013) Optimization of Guideline-Directed Pharmacotherapy for the Treatment of Insomnia at a Veterans Affairs Healthcare System (VAHCS): A Quality Improvement Project
Favorite
3:30 PM – 5:00 PM
(1-014) Impact of a Pharmacist-Led Education Series on Emergency Department Provider Comfortability with Opioid Use Disorder Identification and Management
Favorite
3:30 PM – 5:00 PM
(1-016) Implementing Opt-Out HIV/HCV Testing as a Routine Procedure During Enrollment and Quarterly in a Syringe Services Program (FBSSP)
Favorite
3:30 PM – 5:00 PM
(1-017) Titration of Carbidopa Above the Recommended Dose: Is It Safe and Effective in Patients with Parkinson’s Disease?
Favorite
3:30 PM – 5:00 PM
(1-018) MANAGING DIABETES DURING ACTIVE CANCER TREATMENT: CHALLENGES AND PATIENTS’ UNMET NEEDS
Favorite
3:30 PM – 5:00 PM
(1-019) Effectiveness and safety evaluation of fremanezumab and erenumab in patients with chronic and episodic migraine treated in our hospital.
Favorite
3:30 PM – 5:00 PM
(1-020) Design, implementation and impact on patient safety of a mobile application for patients on antiretroviral therapy
Favorite
3:30 PM – 5:00 PM
(1-021) Impact of Drug Supply Chain Issues on Outpatient Drug Shortages in the Veterans Health Administration, 2017-2020
Favorite
3:30 PM – 5:00 PM
(1-022) Evaluating the Impact of Proactive Pharmacist Recommendations vs. Reactive Clinical Reminder Order Checks on Clinical Decision Making Based on Pharmacogenomic Testing Results
Favorite
3:30 PM – 5:00 PM
(1-023) The Effects of a Standardized Chemotherapy Order-Set on Provider Workflow and Reduction of Errors Associated with Ordering Chemo Regimens: a Chart Review
Favorite
3:30 PM – 5:00 PM
(1-024) Implementation of Empagliflozin in Patients with Pre-Existing Heart Failure with Reduced Ejection Fraction
Favorite
3:30 PM – 5:00 PM
(1-025) Evaluating the Medication Use Process Utilizing Prospective Medication Review of Vaccines in Outpatient Clinics
Favorite
3:30 PM – 5:00 PM
(1-026) Examining the Role and Impact of a Clinical Pharmacy Technician Utilizing the Direct Oral Anticoagulant Population Management Tool
Favorite
3:30 PM – 5:00 PM
(1-027) Evaluation of Current Non-formulary Community Care Prescription Handling Process at The Central Alabama Veterans Health Care System
Favorite
3:30 PM – 5:00 PM
(1-028) Determining Risk Factors for Early or Irregular Discharge in Veterans Enrolled in Residential Rehabilitation Treatment Programs (RRTP)
Favorite
3:30 PM – 5:00 PM
(1-029) Evaluation of a Pharmacist-Driven Intervention on Rehospitalization Rates Among Veterans Enrolled in Home-Based Primary Care
Favorite
3:30 PM – 5:00 PM
(1-030) Standardizing Cognitive Assessments and Monitoring in Veterans with Dementia
Favorite
3:30 PM – 5:00 PM
(1-031) Naltrexone Long-Acting Injection Medication Use Evaluation in a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-032) Evaluation of EKG Monitoring for Citalopram and Escitalopram at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-033) Assessment of medication administration and ordering lapses in patients receiving long-acting injectable paliperidone palmitate
Favorite
3:30 PM – 5:00 PM
(1-034) Retrospective Observational Study Comparing Vancomycin Dosing by Trough levels Alone: An Evaluation of Clinical Outcomes and the Role of AUC-Based Dosing
Favorite
3:30 PM – 5:00 PM
(1-035) Evaluation of Antipsychotic Use for Delirium in the Critical Care Unit at the Alaska Native Medical Center
Favorite
3:30 PM – 5:00 PM
(1-036) Evaluating and Describing Clinical Pharmacist Feedback and Activity in a Newly Consolidated Comprehensive Chronic Care Clinic
Favorite
3:30 PM – 5:00 PM
(1-037) Evaluation of the Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue PCR Assays on Clinical Decision Making
Favorite
3:30 PM – 5:00 PM
(1-038) Impact of Concomitant Cytochrome P450 2D6 Inhibitors on Beta Blocker Safety Outcomes
Favorite
3:30 PM – 5:00 PM
(1-039) VTE and Advanced Stage/Metastatic Cancer Using Long-term Anticoagulation: A Review of Safety and Efficacy in Veterans (VASCULAR)
Favorite
3:30 PM – 5:00 PM
(1-040) Role of Intravenous Methocarbamol to Ameliorate the Use of Opioids in Postoperative Patients: a Retrospective Review
Favorite
3:30 PM – 5:00 PM
(1-041) Assessing Antidepressant De-Prescribing Rates in Veterans with Single Episode Depression Treated in Primary Care Settings
Favorite
3:30 PM – 5:00 PM
(1-042) Phenobarbital vs. Benzodiazepines for the Treatment of Moderate to Severe Alcohol Withdrawal Syndrome in Veterans
Favorite
3:30 PM – 5:00 PM
(1-043) Effectiveness of Medication Restriction in Preventing Suicide among High-Risk Veterans
Favorite
3:30 PM – 5:00 PM
(1-044) Retrospective Review of Adjuvant Endocrine Therapy for Hormone-Receptor Positive Breast Cancer in Veterans
Favorite
3:30 PM – 5:00 PM
(1-045) The impact of implementing a venous thromboembolism prophylaxis protocol at a tribal health care inpatient facility
Favorite
3:30 PM – 5:00 PM
(1-046) Intravenous Pump Guardrail Usage Optimization at a Tribal Health Facility
Favorite
3:30 PM – 5:00 PM
(1-047) Role of Glucagon‐Like Peptide 1 (GLP‐1) Agonists in Alcohol Use Disorder
Favorite
3:30 PM – 5:00 PM
(1-048) Impact of an Interdisciplinary Pharmacy-Based Weight Loss Program
Favorite
3:30 PM – 5:00 PM
(1-049) Comparative Effectiveness of FDA-Approved Injectable and Non-Injectable Pharmacologic Medications for the Treatment of Obesity within a Federally Qualified Healthcare Center
Favorite
3:30 PM – 5:00 PM
(1-050) Impact of Pharmacist-Led Smoking Cessation Interventions on Tobacco Cessation Rates in a Federally Qualified Health Center
Favorite
3:30 PM – 5:00 PM
(1-051) Impact of Pharmacogenomic Testing on Medication Changes in Veterans
Favorite
3:30 PM – 5:00 PM
(1-052) Evaluation of pharmacist led weight management medication management versus standard follow up
Favorite
3:30 PM – 5:00 PM
(1-053) Evaluation of Vitamin B12 Monitoring in Veterans on Long-term Metformin Therapy at a Single Department of Veteran Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-054) Assessing Use of Inhaled Corticosteroid Therapy in Veterans with COPD
Favorite
3:30 PM – 5:00 PM
(1-055) Analysis of Prescribing Patterns for Nicotine Replacement Therapy (NRT) at Veterans Healthcare System of the Ozarks (VHSO)
Favorite
3:30 PM – 5:00 PM
(1-056) Evaluating Guideline Adherence to Post Antibiotic Monitoring in Infective Endocarditis
Favorite
3:30 PM – 5:00 PM
(1-057) Evaluation of Patients on Paliperidone Palmitate to Extend Injection Frequency at VA Loma Linda Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-058) Implementing a Dot-Phrase Computer Tool to Optimize Pharmacist Documentation and Ordering Processes
Favorite
3:30 PM – 5:00 PM
(1-059) Implementation of Pharmacist Training Documentation for Non-Chemotherapy Medications Under the Risk Evaluation and Mitigation Strategies Program
Favorite
3:30 PM – 5:00 PM
(1-060) Measuring Adherence to Facility Clostridiodes difficile Treatment Guidelines
Favorite
3:30 PM – 5:00 PM
(1-061) Improving Screening Process for Chronic Kidney Disease (CKD) in Veterans with Hypertension
Favorite
3:30 PM – 5:00 PM
(1-062) Implementation of Hematology/Oncology Clinic Orders for Infusion Center
Favorite
3:30 PM – 5:00 PM
(1-063) Expanding Heart Failure Discharge Education Process to Pharmacy Students
Favorite
3:30 PM – 5:00 PM
(1-064) Retrospective Evaluation of the Appropriateness of Semaglutide Continuation for Weight Loss among a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-065) Evaluation of the appropriateness of discharge antibiotic duration for urinary tract infections at Veterans Affairs Central California Health Care System (VACCHCS)
Favorite
3:30 PM – 5:00 PM
(1-066) Evaluation of Empagliflozin Initiation During Hospitalization for Heart Failure Patients at a Federally Affiliated Institution
Favorite
3:30 PM – 5:00 PM
(1-068) Effects of Implementing a Quality Improvement Program for Lipid Optimization in Veterans with Atherosclerotic Cardiovascular Disease (ASCVD) at Veterans Affairs Greater Los Angeles Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-069) Addressing barriers to opioid risk mitigation in the emergency department utilizing a comprehensive template
Favorite
3:30 PM – 5:00 PM
(1-070) Anticoagulation Stewardship at VA Loma Linda: Identifying and Intervening Untreated Atrial Fibrillation/Flutter Veterans where Anticoagulation Therapy is Indicated
Favorite
3:30 PM – 5:00 PM
(1-071) Describing Adverse Drug Reactions Associated with Oral Anticancer Treatment for Prostate Cancer in a Single-Center Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-072) Impact of Primary Care Pharmacists on Heart Failure Management
Favorite
3:30 PM – 5:00 PM
(1-073) Evaluation of the Use of Osteoporosis Medications Following a Hip Fracture in the Veteran Population at the VAGLAHS
Favorite
3:30 PM – 5:00 PM
(1-074) Management of Acute Psychosis Secondary to a Medical Etiology Possibly from Frontal Lobe Meningioma
Favorite
3:30 PM – 5:00 PM
(1-075) Evaluation of Treatment for Hepatocellular Carcinoma (HCC) Use Among Patients at Veterans Affairs Central California Health Care System (VACCHCS)
Favorite
3:30 PM – 5:00 PM
(1-076) Evaluation of Clinical Pharmacy Technician Workflow Modifications in the Direct Oral Anticoagulant Dashboard
Favorite
3:30 PM – 5:00 PM
(1-077) Impact of Pharmacist-managed Drug-Culture Mismatch Review in the Emergency Department (ED) at a Veterans Affairs Facility
Favorite
3:30 PM – 5:00 PM
(1-078) Assessing the Utilization and Discontinuation Trends of Extended-Release Buprenorphine at a Veteran Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-079) Melatonin Medication Use Evaluation at VA Connecticut Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-080) Evaluation of Guideline Concordant Prescribing and Administration of Prophylaxis for Prevention of Surgical Site Infections in a Veterans Affairs (VA) Healthcare System Hospital
Favorite
3:30 PM – 5:00 PM
(1-081) Safety and Tolerability of SGLT2 Inhibitors in Older Adults at VA Connecticut Healthcare System (VACHS)
Favorite
3:30 PM – 5:00 PM
(1-082) Evaluation of Inflammatory Bowel Disease Dashboard for Outpatient Treatment
Favorite
3:30 PM – 5:00 PM
(1-083) Evaluation of the Appropriate Prescribing of Nutritional Supplements by Dietitians at a Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-084) Evaluation of Medications Involved in Overdoses in a Veterans Affairs Population
Favorite
3:30 PM – 5:00 PM
(1-085) Evaluation of the Implementation of Pharmacogenomic Testing Services at a Veterans Affairs Hospital
Favorite
3:30 PM – 5:00 PM
(1-086) Evaluation of Indications for Obtaining Urinalysis and Urine Cultures in a Veteran Affairs Community Living Center (CLC)
Favorite
3:30 PM – 5:00 PM
(1-087) Evaluation of retinal exams and hemoglobin A1c monitoring in a Veterans Affairs population treated with Ozempic (semaglutide) for type 2 diabetes
Favorite
3:30 PM – 5:00 PM
(1-088) Evaluation of Chatbot Responses in Pharmacy Practice
Favorite
3:30 PM – 5:00 PM
(1-089) Evaluation of First-line and Alternative Pharmacotherapy Approaches for Post-Traumatic Stress Disorder in a Residential Post-Traumatic Stress Disorder Treatment Setting
Favorite
3:30 PM – 5:00 PM
(1-090) Evaluation of the Utilization, Efficacy, and Safety of Weight Loss Medications in a Veterans Affairs (VA) Population
Favorite
3:30 PM – 5:00 PM
(1-091) Pharmacist-led Interventions on Adherence to Standards of Care in HIV Pre-Exposure Prophylaxis Prescribing and Monitoring
Favorite
3:30 PM – 5:00 PM
(1-092) Comparing Pharmacist vs Application Management System Outreach for Scheduling Clinical Pharmacist Practitioner Appointments to Reduce Gender Disparities in Diabetic Women on Statins
Favorite
3:30 PM – 5:00 PM
(1-093) Reduction in Outpatient Antimicrobial Prescribing Rates for Urinary Tract Infections in the Emergency Department
Favorite
3:30 PM – 5:00 PM
(1-094) Expansion of Clinical Pharmacy Services Within the Emergency Department
Favorite
3:30 PM – 5:00 PM
(1-095) Impact of Expanding Pharmacist Scope of Practice Through Management of Gout, Hypothyroidism, and Diabetic Neuropathy in Primary Care at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-096) Implementation and Utilization of Pharmacogenomics Testing for Veterans at James A. Haley Veterans’ Hospital
Favorite
3:30 PM – 5:00 PM
(1-097) Evaluation of Prior Authorization Drug Request Utilization for Care in the Community Prescriptions: A Quality Improvement Project
Favorite
3:30 PM – 5:00 PM
(1-098) Expansion & Optimization of a Pharmacy-Run Inpatient Anticoagulation Service at James A. Haley Veterans’ Hospital
Favorite
3:30 PM – 5:00 PM
(1-099) Medication Use Evaluation and Expansion of Weight Loss Management into Clinical Pharmacy Practitioners’ Clinics at James A. Haley Veterans’ Hospital
Favorite
3:30 PM – 5:00 PM
(1-100) Review of Inpatient Pharmacy Tobacco Cessation Intervention and Outcomes
Favorite
3:30 PM – 5:00 PM
(1-101) Evaluating Outcomes of Psychotropic Drug Safety Initiative (PDSI) Management System for Management of Stimulant Use at a Veterans Health Medical Center
Favorite
3:30 PM – 5:00 PM
(1-103) Evaluation of the Use of Aripiprazole Long Acting Psychotropic Injectables at the Miami VA Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-105) Expanding Implementation of the VIONE Population Management Tool to Decrease Polypharmacy at the Miami VA Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-106) Impact of Pharmacy-led Addition of SGLT2i in Patients Treated for HFrEF via the Population Management Tool in Accordance with Guideline Directed Medical Therapy
Favorite
3:30 PM – 5:00 PM
(1-107) Evaluation of Risk Mitigation Strategies for Teratogenic Drugs
Favorite
3:30 PM – 5:00 PM
(1-108) Weight and Glycated Hemoglobin Reduction with Glucagon-Like-Peptide-1 Receptor Agonists According to Weight Category in Veterans with Type 2 Diabetes
Favorite
3:30 PM – 5:00 PM
(1-109) Clozapine Induced Constipation or Paralytic Ileus in Patients Concomitantly Taking Anticholinergic Medications versus Taking Clozapine Alone
Favorite
3:30 PM – 5:00 PM
(1-110) Evaluation of Insulin Dose Percent Change After Initiation of Semaglutide in Patients Diagnosed with Type 2 Diabetes Mellitus at North Florida/South Georgia Veterans Health System
Favorite
3:30 PM – 5:00 PM
(1-111) Fidaxomicin vs. Vancomycin in High-risk Adults with a Clostridioides difficile Infection
Favorite
3:30 PM – 5:00 PM
(1-112) Incidence of statin-associated musculoskeletal symptoms in Veterans with altered SLCO1B1 phenotype
Favorite
3:30 PM – 5:00 PM
(1-113) The Effect of Hormonal Agents for the Treatment of Prostate Cancer on Blood Pressure and Glycemic Control in Veterans
Favorite
3:30 PM – 5:00 PM
(1-114) Comparison of Prophylactic Anti-inflammatory Agents Initiated Concomitantly With Urate-Lowering Therapy for Gout Prophylaxis
Favorite
3:30 PM – 5:00 PM
(1-115) Evaluation of Subcutaneous Depot Medroxyprogesterone Acetate for Patient Self-Administration at North Florida/South Georgia Veterans Health System
Favorite
3:30 PM – 5:00 PM
(1-116) Retrospective review of patients receiving concomitant allopurinol and thiazides with history of gout and/or hyperuricemia
Favorite
3:30 PM – 5:00 PM
(1-117) Evaluation of Clinical Pharmacist Practitioner Interventions in a Pharmacist-Run Heart Failure Shared Medical Appointment
Favorite
3:30 PM – 5:00 PM
(1-118) Effectiveness of an Interdisciplinary Overdose Review Team Chart Review
Favorite
3:30 PM – 5:00 PM
(1-119) Development and Implementation of an Extended Infusion Piperacillin/Tazobactam Dosing Protocol
Favorite
3:30 PM – 5:00 PM
(1-120) Decreasing Inappropriate Antipseudomonal Antibiotic Use for Diabetic Foot Infections in the Acute Care Setting at Orlando Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-121) Evaluating Current Periprocedural/Perioperative Anticoagulation Management for Direct Oral Anticoagulants (DOAC) and Warfarin
Favorite
3:30 PM – 5:00 PM
(1-122) Evaluation of Dose-Dependent Relationship Between Mirtazapine and Weight Gain
Favorite
3:30 PM – 5:00 PM
(1-123) Comparison of sotalol and dofetilide for successful initiation and continuation in atrial fibrillation patients
Favorite
3:30 PM – 5:00 PM
(1-124) Evaluating Practices for Prescribing Buprenorphine for Chronic Pain
Favorite
3:30 PM – 5:00 PM
(1-125) Quality Assurance Evaluation of Bevacizumab and Ramucirumab Therapy at the West Palm Beach Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-126) Evaluation of Long-Acting Injectable Antipsychotics in Veterans with Schizophrenia or Schizoaffective Disorder
Favorite
3:30 PM – 5:00 PM
(1-127) Stroke Prevention in Atrial Fibrillation/Flutter: Targeting the Untreated While Prioritizing Disparities
Favorite
3:30 PM – 5:00 PM
(1-128) Immune Checkpoint Inhibitors’ Related Thyroid Dysfunction in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-129) Reducing Gender Disparities in Statin Therapy Among Veterans with Type II Diabetes and/or Cardiovascular Disease
Favorite
3:30 PM – 5:00 PM
(1-130) Utilization of Local Chart Review Tracker to Improve Misdiagnosis and Undertreatment of Opioid Use Disorder
Favorite
3:30 PM – 5:00 PM
(1-131) Providing Targeted Outreach for Pharmacogenomic Testing to Actionable Veterans with POST-TRAUMATIC STRESS DISORDER to Guide Psychopharmacologic Treatment
Favorite
3:30 PM – 5:00 PM
(1-132) Impact of Provider Location on Oral Anticoagulation Prescribing Patterns in Veterans with Atrial Fibrillation or Flutter
Favorite
3:30 PM – 5:00 PM
(1-133) Evaluation of Predetermined Health Disparity Impact on Patients with Atrial Fibrillation or Flutter Without Stroke Prophylaxis at a Veteran Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-134) Implementation of Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP) in the Primary Care Setting Through Targeted Clinician and Veteran Education
Favorite
3:30 PM – 5:00 PM
(1-135) Aspirin Deprescribing or Proton Pump Inhibitor Prescribing in Patients on Concomitant Aspirin and Oral Anticoagulation Therapy
Favorite
3:30 PM – 5:00 PM
(1-136) Pharmacist Led Continuous Glucose Monitor Initiation: Time Spent and Impact on Veteran Care Before Transitioning Management to the Primary Care Team
Favorite
3:30 PM – 5:00 PM
(1-137) Evaluation of Empagliflozin Prescribing Practices within the Boise VA Medical Center
Favorite
3:30 PM – 5:00 PM
(1-138) Deprescribing Sulfonylureas in Patients Above the Age of 65 Within the Boise VA Medical Center
Favorite
3:30 PM – 5:00 PM
(1-139) Utilizing the VIONE Dashboard to Identify the Impact of Deprescribing in Older Adults
Favorite
3:30 PM – 5:00 PM
(1-140) Evaluation of Accuracy: Tech-Check-Tech Protocol Implementation at the Boise VA Medical Center (BVAMC)
Favorite
3:30 PM – 5:00 PM
(1-141) Initiative to Increase Vaccination Rates of Veterans on Immunocompromising Rheumatologic Medication
Favorite
3:30 PM – 5:00 PM
(1-142) Evaluation of Metformin Prescribing Practices in Patients with Prediabetes or History of Gestational Diabetes Within the Women’s Wellness Clinic at the Boise VA Medical Center
Favorite
3:30 PM – 5:00 PM
(1-143) Implementation of a Syringe Services Program at Two Veterans Affairs Medical Centers
Favorite
3:30 PM – 5:00 PM
(1-144) Implementation of pharmacist-led polycystic ovary syndrome (PCOS) medication management clinics for women veterans
Favorite
3:30 PM – 5:00 PM
(1-145) Assessing Tobacco Cessation Success Rates and Pharmacist Involvement at a Federal Health Care Center (FHCC)
Favorite
3:30 PM – 5:00 PM
(1-146) Human immunodeficiency virus (HIV) Incidence and Pre-Exposure Prophylaxis (PrEP) prescribing trends within a Federal Health Care Center
Favorite
3:30 PM – 5:00 PM
(1-147) The impact of urine cultures processed in a VA associated laboratory compared to a non-VA associated laboratory on the treatment of inpatient urinary tract infections.
Favorite
3:30 PM – 5:00 PM
(1-148) Minimizing Inappropriate Azithromycin Prescriptions in Veterans Affairs Emergency Departments and Outpatient Clinics via Order Menu-Based Interventions
Favorite
3:30 PM – 5:00 PM
(1-149) Evaluation of the Use of Triptans in Patients with Cardiovascular and/or Cerebrovascular Disease
Favorite
3:30 PM – 5:00 PM
(1-150) Treatment Patterns, Safety, and Effectiveness of Rituximab Originator versus Rituximab-pvvr within the Veterans Health Administration
Favorite
3:30 PM – 5:00 PM
(1-151) Assessing the impact of a pharmacist-led harm reduction clinic at a rural Veterans Affairs (VA) healthcare system
Favorite
3:30 PM – 5:00 PM
(1-152) Evaluating Vaccine Documentation at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-153) Retrospective analysis of direct oral anticoagulant hold recommendations for gastrointestinal procedures by an outpatient anticoagulation clinic
Favorite
3:30 PM – 5:00 PM
(1-154) Impact of Rapid Blood Culture Identification on Antibiotic De-escalation at a Veteran Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-155) Comparison of Prescribing Patterns of Naloxone in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-156) Outcomes from the use of cefazolin for surgical prophylaxis in penicillin allergic patients
Favorite
3:30 PM – 5:00 PM
(1-157) A Survey of Pharmacists on Naloxone Prescribing: Where to Next?
Favorite
3:30 PM – 5:00 PM
(1-158) Analysis of letters of recommendation for predictive factors for admission into a professional pharmacy curriculum
Favorite
3:30 PM – 5:00 PM
(1-159) Impact of the Implementation of Diabetes Counseling at Discharge from a Community Living Center on Glycemic Control and Readmission Rates
Favorite
3:30 PM – 5:00 PM
(1-160) Implementation of the Allergy to Beta Lactam Evaluation (ABLE) Initiative at VACIHCS to Guide Antibiotic Selection in Surgical Patients
Favorite
3:30 PM – 5:00 PM
(1-161) Evaluation of Methicillin-resistant Staphylococcus aureus (MRSA) Nares Screening on the Duration and De-escalation of Vancomycin Therapy in Veteran Patients with Pneumonia
Favorite
3:30 PM – 5:00 PM
(1-162) Title: Comparison of unique hospitalization rates between initiating long-acting injectable aripiprazole and aripiprazole lauroxil for psychiatric conditions
Favorite
3:30 PM – 5:00 PM
(1-163) Development and Implementation of Competency Self-Assessments for a Centralized Health-System Pharmacist Training Program
Favorite
3:30 PM – 5:00 PM
(1-164) Medication Use Evaluation of the Safety and Effectiveness of Empagliflozin
Favorite
3:30 PM – 5:00 PM
(1-165) Investigating Safety and Efficacy of Daptomycin Dosing Strategies at a Single Veterans Affairs Institution
Favorite
3:30 PM – 5:00 PM
(1-166) Comparison of Outcomes in Patients with Asymptomatic Bacteriuria Treated with Antibiotics versus Untreated
Favorite
3:30 PM – 5:00 PM
(1-167) Evaluation of a pharmacist-driven inhaled corticosteroid de-escalation intervention in veterans
Favorite
3:30 PM – 5:00 PM
(1-168) Opioid Allergy Cross-reactivity in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-169) Impact of Pharmacist Education on Veterans Hospitalized with Hypertension
Favorite
3:30 PM – 5:00 PM
(1-170) A retrospective case-control study evaluating medications associated with inpatient falls in a single Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-171) Impact of a Clinical Pharmacist in an Infusion Specialty Clinic on Cost Savings and Veteran and Provider Satisfaction at Veterans Affairs Maine Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-172) Implementation of the Allergy to Beta-Lactam Evaluation (ABLE) Initiative at VA Maine
Favorite
3:30 PM – 5:00 PM
(1-173) Impact of Pharmacy Intervention on Lipid Lowering in Veterans with ASCVD Enrolled in the Veterans Affairs Lipid Optimization Reimagined Quality Improvement Program (VALOR-QI)
Favorite
3:30 PM – 5:00 PM
(1-174) Reducing the Frequency of Medication Administration at the VAMHCS Community Living Center
Favorite
3:30 PM – 5:00 PM
(1-175) Evaluating Bleeding Events in the Elderly Veteran Population Receiving FDA-Approved Doses of Apixaban or Rivaroxaban
Favorite
3:30 PM – 5:00 PM
(1-176) Assessing Tolerability Upon Switching From Maximum Dose Liraglutide to Semaglutide for Obesity
Favorite
3:30 PM – 5:00 PM
(1-177) Evaluation of a Pharmacist-Led Intervention to Deprescribe Nonsteroidal Anti-Inflammatory Drugs in Patients with Heart Failure
Favorite
3:30 PM – 5:00 PM
(1-178) Impact of Peer Education on Pharmacy Staff Comfort with Syringe Service Programs and Harm Reduction Strategies
Favorite
3:30 PM – 5:00 PM
(1-179) Effectiveness of an interprofessional workgroup for the implementation of Disease Modifying Therapy for Alzheimer’s Disease (DMTAD): a lecanemab infusion clinic
Favorite
3:30 PM – 5:00 PM
(1-180) Oral versus Intravenous Antibiotics in Bone and Joint Infection Treatment at the Veterans Affairs Ann Arbor Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-181) Impact of a Resident Run Weight Management Clinic on Health Outcomes in a Primary Care Setting within the Veterans Health Administration
Favorite
3:30 PM – 5:00 PM
(1-182) Evaluation of Subcutaneous leuprolide Failure in Veteran Patients with Prostate Cancer Among Varying Doses
Favorite
3:30 PM – 5:00 PM
(1-183) Evaluation of Pharmacy-based Recommendations within a Comprehensive Geriatric Assessment Multidisciplinary Team
Favorite
3:30 PM – 5:00 PM
(1-184) Veterans Affairs Magnesium in the Emergency Department for Atrial Fibrillation: A Randomized, Double-blinded, Placebo-controlled, Pilot Study
Favorite
3:30 PM – 5:00 PM
(1-185) Early Optimization of Guideline-Directed Medical Therapy in Veterans with Heart Failure
Favorite
3:30 PM – 5:00 PM
(1-186) Increased Access to Suboxone in the Emergency Department with a Pharmacist-Led Initiative
Favorite
3:30 PM – 5:00 PM
(1-187) The Prevalence of Calcitonin Gene-Related Peptide Antagonist and Botulinum Toxin Combination Therapy for Migraine Prevention within a VA Health Care System
Favorite
3:30 PM – 5:00 PM
(1-188) Evaluating Provider Acceptance of Pharmacy Recommendations to Deprescribe Sulfonylureas in Patients at Elevated Hypoglycemic Risk
Favorite
3:30 PM – 5:00 PM
(1-189) Impact of Pharmacist Intervention on IV Iron Usage Among Patients with Heart Failure at the Minneapolis Veterans Affairs Health Care System (MVAHCS)
Favorite
3:30 PM – 5:00 PM
(1-190) Evaluating the Impact of Secure Messaging on Naloxone Prescribing to Veterans At-Risk for Opioid Overdose
Favorite
3:30 PM – 5:00 PM
(1-191) Analysis of the effectiveness of oral weight loss medications: A retrospective chart review at the Minneapolis Veterans Affairs Health Care System (MVAHCS)
Favorite
3:30 PM – 5:00 PM
(1-192) Evaluating Women’s Health and Contraception Management Needs to Determine Expansion Opportunities within the Pharmacy-based Primary Care Clinic at Red Lake Indian Health Service Hospital
Favorite
3:30 PM – 5:00 PM
(1-193) Vaccination Rates in Veterans at the Minneapolis Veterans Affairs Health Care System Living with an Immunocompromising Condition
Favorite
3:30 PM – 5:00 PM
(1-194) Enhancing Primary Care Prescribing of PCSK9 Inhibitors for Secondary Prevention of ASCVD in High Risk Patients at the Minneapolis Veterans Affairs Health Care System (MVAHCS)
Favorite
3:30 PM – 5:00 PM
(1-195) Perception of Pre-exposure Prophylaxis in Veterans with Substance Use Disorder
Favorite
3:30 PM – 5:00 PM
(1-196) Investigating the Influence of Statin Prescription Labeling on the Rate of Statin-Associated Muscle Symptom Adverse Drug Reaction Reports
Favorite
3:30 PM – 5:00 PM
(1-197) Achievement of guideline directed therapy of target dosing in primary care Veterans with heart failure reduced ejection fraction at G.V. Sonny Montgomery VA Medical Center
Favorite
3:30 PM – 5:00 PM
(1-198) Kratom: A Veteran’s Ally or Adversary?
Favorite
3:30 PM – 5:00 PM
(1-199) Impact of Implementing the Allergy to Beta-Lactam Evaluation in the Outpatient Setting within a VA Medical Center
Favorite
3:30 PM – 5:00 PM
(1-200) Evaluation of Pharmacist Impact on Risk Reduction via Deprescribing Interventions Provided to Home-Based Primary Care (HBPC) Patients
Favorite
3:30 PM – 5:00 PM
(1-201) Evaluation of Clinical Pharmacist Medication Management Within the MOVE! Weight Management Program for Veterans
Favorite
3:30 PM – 5:00 PM
(1-202) Incidence of clinically significant worsening or new onset diabetic retinopathy after semaglutide or dulaglutide initiation
Favorite
3:30 PM – 5:00 PM
(1-203) Evaluation of the Effect of Glucagon-Like Peptide 1 (GLP-1) Agonists on Elevated Transaminases at an Academic Medical Center
Favorite
3:30 PM – 5:00 PM
(1-204) Increasing Access to Naloxone in Veterans Receiving Opioids through Community Care
Favorite
3:30 PM – 5:00 PM
(1-205) Evaluation of a Pharmacy-Led Vancomycin Dosing Protocol Utilizing Area Under the Curve to Minimum Inhibitory Concentration Ratio at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-206) Evaluation of Outpatient Chronic Pain Management with Buprenorphine Products After Change in Veterans Affairs (VA) Formulary Status
Favorite
3:30 PM – 5:00 PM
(1-207) Crow Service Unit Every patient, Every encounter, Every recommend vaccine (E3) Pilot Initiative: Increasing Vaccination Rates in American Indians and Alaskan Natives
Favorite
3:30 PM – 5:00 PM
(1-208) Evaluation of Pharmacist Impact on Response Time to Positive Microbial Cultures within the Emergency Department
Favorite
3:30 PM – 5:00 PM
(1-209) Evaluation of a Phenobarbital Protocol for the Management of Acute Alcohol Withdrawal Syndrome
Favorite
3:30 PM – 5:00 PM
(1-210) Evaluation of Aspirin Use for Primary Prevention in Veterans on Chronic Oral Anticoagulation
Favorite
3:30 PM – 5:00 PM
(1-211) Evaluation of Bleeding Risk for Veterans on Warfarin
Favorite
3:30 PM – 5:00 PM
(1-212) Outcomes from a Pharmacist-Led Travel Clinic
Favorite
3:30 PM – 5:00 PM
(1-213) Clinical and Economic Impact of Weight Loss Medications in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-214) Chronic Obstructive Pulmonary Disease Exacerbation Medication Kits for High-Risk Veterans Receiving Care from the Diamond View VA Clinic within VA Sierra Nevada Health Care System
Favorite
3:30 PM – 5:00 PM
(1-215) Association of medication use on falls in geriatric residents of a VA community living center
Favorite
3:30 PM – 5:00 PM
(1-216) Evaluating the Impact of the Women's Health Clinical Pharmacy Practitioner in Providing Contraceptive Care at the Veterans Affairs Sierra Nevada Health Care System
Favorite
3:30 PM – 5:00 PM
(1-217) Implementation of A Pharmacist-Driven Long-Acting Injectable Antipsychotic Stewardship Program at VA Sierra Nevada Health Care System
Favorite
3:30 PM – 5:00 PM
(1-218) Implementation of an Osteoporosis Screening Tool for Male Veterans in the Ambulatory Care Setting at VASNHCS
Favorite
3:30 PM – 5:00 PM
(1-219) Impact of Direct-to-Consumer Education on Treatment of Alcohol Use Disorder Within a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-220) Stoke Prevention in Atrial Fibrillation/Flutter - Targeting the Untreated with a Focus on Health Disparities - At VA Sierra Nevada Medical Center
Favorite
3:30 PM – 5:00 PM
(1-221) Analysis of Veterans Affairs Southern Nevada Healthcare System use of Banana Bags in AUD Patients and Discontinuation of Therapy During Transition of Care
Favorite
3:30 PM – 5:00 PM
(1-222) Assessment and prevention of therapy-related infections in immunocompromised Veterans
Favorite
3:30 PM – 5:00 PM
(1-223) A Cost Saving Analysis of Topical Tranexamic Acid and Topical Thrombin in the use of Epistaxis in the Setting of the Emergency Department
Favorite
3:30 PM – 5:00 PM
(1-224) Methicillin-resistant Staphylococcus aureus Nasal Polymerase Chain Reaction Screening as Antimicrobial Stewardship Tool for Avoiding Overuse of Vancomycin in Skin, Soft Tissue, Bone and Joint Infections
Favorite
3:30 PM – 5:00 PM
(1-225) Evaluation of Dual Antipsychotic Use and Clozapine for Treatment Resistant Schizophrenia at a Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-226) Evaluating the effect of glycemic control in patients transitioning from liraglutide to semaglutide at a Veteran Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-227) Implementing the Use of Continuous Glucose Monitoring Devices into a Pharmacist-Led Diabetes Management Clinic
Favorite
3:30 PM – 5:00 PM
(1-228) Development and Assessment of a Collaborative Practice Agreement for Integration of Heart Failure Pharmacy Services into Anticoagulation Clinic
Favorite
3:30 PM – 5:00 PM
(1-229) Design and Implementation of a Consult Program for Penicillin Allergy Delabeling in Emergency Room Patients
Favorite
3:30 PM – 5:00 PM
(1-230) Assessing Impact of Pharmacy Point-of-Sale Operations on Third-Party Revenue at an Indian Health Service Facility.
Favorite
3:30 PM – 5:00 PM
(1-231) Impact of Pharmacy-Initiated Lab Ordering on HIV Pre-Exposure Prophylaxis (PrEP) Monitoring Rates
Favorite
3:30 PM – 5:00 PM
(1-232) Improving heart failure prescribing practices through physician education and clinical decision support system updates in an American Indian/Alaska Native population
Favorite
3:30 PM – 5:00 PM
(1-233) Change in CD4 count after initiation of second-generation INSTI-containing ART regimens in patients living with HIV
Favorite
3:30 PM – 5:00 PM
(1-234) Evaluation of Osteomyelitis in Spinal Cord Injury Patients
Favorite
3:30 PM – 5:00 PM
(1-235) Evaluating Time to Administration of Stat Intravenous Antibiotics
Favorite
3:30 PM – 5:00 PM
(1-236) Appropriateness of Clostridiodes difficile Testing in Hospitalized Patients Pre- and Post- Testing Restrictions
Favorite
3:30 PM – 5:00 PM
(1-237) Prevalence of Methicillin-Resistant Staphylococcus aureus and Utility of Screening for Colonization in Diabetic Foot Infections or Osteomyelitis at a Bronx Veterans’ Hospital
Favorite
3:30 PM – 5:00 PM
(1-238) Evaluating Effectiveness of Pharmacy Interventions in Naloxone Prescribing Practices for Patients at Risk of Opioid Overdose at Northport Veteran’s Affairs Medical Center (VAMC)
Favorite
3:30 PM – 5:00 PM
(1-239) Effectiveness of Continuous Glucose Monitoring Systems in A1c Reduction in Patients with Type 2 Diabetes Mellitus at Northport Veteran’s Affairs Medical Center (VAMC)
Favorite
3:30 PM – 5:00 PM
(1-240) Urine Drug Screens: Assessing Prescriber Interpretation and Outcomes in Chronic Opioid Therapy
Favorite
3:30 PM – 5:00 PM
(1-241) Impact of Magnetic Resonance Imaging on Re-Amputation Rates in Diabetic Foot Osteomyelitis: A Retrospective Study
Favorite
3:30 PM – 5:00 PM
(1-242) Evaluation of Tafamidis Treatment in Veterans Diagnosed with Transthyretin Amyloid Cardiomyopathy
Favorite
3:30 PM – 5:00 PM
(1-243) Expansion of Women's Health Pharmacy at the VA Finger Lakes Healthcare System: Minimizing the Risk of Cardiometabolic Disease through Interdisciplinary Team Interventions
Favorite
3:30 PM – 5:00 PM
(1-244) Evaluation of appropriate prescribing of amoxicillin/clavulanate in patients at VA HVHCS
Favorite
3:30 PM – 5:00 PM
(1-245) Medication Use Evaluation of the Appropriateness of Azithromycin in Outpatient Veterans
Favorite
3:30 PM – 5:00 PM
(1-246) Evaluation of Urinary Tract and Genital Infections Associated with Empagliflozin in Comparison to Semaglutide in Veterans Diagnosed with Type 2 Diabetes Mellitus
Favorite
3:30 PM – 5:00 PM
(1-247) Impact of Pharmacist Interventions in Veterans with Chronic Obstructive Pulmonary Disease
Favorite
3:30 PM – 5:00 PM
(1-248) Evaluation of appropriate antibiotic-use in COPD exacerbations
Favorite
3:30 PM – 5:00 PM
(1-249) Impact of a Stewardship Program on Veterans Admitted for Urinary Tract Infection
Favorite
3:30 PM – 5:00 PM
(1-250) Evaluation of Antibiotic Use in the Treatment of Asymptomatic Bacteriuria in Geriatric Veterans
Favorite
3:30 PM – 5:00 PM
(1-251) Retrospective Review of Antidepressant Initiation and Follow-Up Within the Primary Care Setting at the Stratton VA Medical Center
Favorite
3:30 PM – 5:00 PM
(1-252) Identifying racial disparities in the management of heart failure with reduced ejection fraction
Favorite
3:30 PM – 5:00 PM
(1-253) Impact of Implementing a Medication Management Pharmacist for Veterans in a Residential Rehabilitation Treatment Program
Favorite
3:30 PM – 5:00 PM
(1-254) Ensuring Guideline-Directed Medical Therapy in patients with Heart Failure with Reduced Ejection Fraction through Pharmacist Consultation in the Primary Care Setting
Favorite
3:30 PM – 5:00 PM
(1-255) Narrowing the Spectrum: Evaluating Impact of Pharmacist-Led Antimicrobial Stewardship Efforts
Favorite
3:30 PM – 5:00 PM
(1-256) Evaluating the Association of Antidepressant Serotonin Transporter Affinity with Bleeding Events in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-257) Impact of a Phenobarbital Alcohol Withdrawal Treatment Pathway on Hospital Length of Stay in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-258) Understanding the Impact of Unrestricting Atypical Antipsychotic Prescribing on Medical and Surgical Floors
Favorite
3:30 PM – 5:00 PM
(1-259) Characterization of Pharmacist Practice in a Veterans Affairs Community Living Center (CLC)
Favorite
3:30 PM – 5:00 PM
(1-261) Optimization of a clinical pharmacy medication review process within a geriatric emergency department at a Veteran Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-262) Implementation of a Pharmacist-Led Initiative to Deprescribe Aspirin for Primary Prevention in a Geriatric Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-263) Impact of a Pharmacist-Led Weight Loss Medication Management Service in a Veteran Community
Favorite
3:30 PM – 5:00 PM
(1-264) Pharmacist-Led Initiative to Deprescribe Tramadol and Semi-Synthetic Opiates in Veterans with Altered CYP2D6 Metabolism Based on Pharmacogenomic Test Results
Favorite
3:30 PM – 5:00 PM
(1-265) Stroke Prevention in Atrial Fibrillation/Flutter: Targeting the Untreated While Prioritizing Health Disparities at the Salisbury VA Health Care System
Favorite
3:30 PM – 5:00 PM
(1-266) Evaluation of the Impact of a Pharmacy-Based Chronic Obstructive Pulmonary Disease (COPD) Quality Improvement Project at a Rural Indian Health Service Facility
Favorite
3:30 PM – 5:00 PM
(1-267) Implementation of a Syringe Services Program (SSP) at a Rural Veteran Affairs Medical Center Main Facility and Outpatient Clinics: A Harm Reduction Project
Favorite
3:30 PM – 5:00 PM
(1-268) Evaluation of Opioid, Benzodiazepine, and Z-Hypnotic Co-Prescribing Policy Sustainability at the Cincinnati Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-269) Evaluation of medication error occurrence in discharge medication reconciliations to skilled nursing facilities (SNF) at the Cincinnati Veterans Affairs Medical Center (CVAMC)
Favorite
3:30 PM – 5:00 PM
(1-270) Pharmacist Transitions of Care Pilot at the Cincinnati Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-271) Evaluation of Clinical Pharmacist Practitioner Interventions and Potential Workload in a Home-Based Primary Care Patient Population
Favorite
3:30 PM – 5:00 PM
(1-272) Evaluating the Appropriate use of Erythropoietin Stimulating Agents in Patients with Chronic Kidney Disease
Favorite
3:30 PM – 5:00 PM
(1-273) Examining Prescribing Trends of BEERS Medications in Veteran’s Enrolled in VA HBPC Programs.
Favorite
3:30 PM – 5:00 PM
(1-274) Implementing an Improved Process for Offering Pharmacogenomic Testing for Veterans in Clinical Pharmacist Practitioner Led Clinics at the Veterans Affairs Central Ohio Health Care System
Favorite
3:30 PM – 5:00 PM
(1-275) Implementing Process Improvement for Veterans Affairs Adverse Drug Reporting Post-implementation of the federal Electronic Health Record (EHR) at the VA Central Ohio Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-276) Implementation of a Distribution Pharmacy Controlled Non-Formulary Optimization Process
Favorite
3:30 PM – 5:00 PM
(1-277) Implementation of a Pharmacist Managed Remote Monitoring Hypertension Program for American Indians and Alaska Natives in a Rural Ambulatory Care Tribal Health System.
Favorite
3:30 PM – 5:00 PM
(1-278) Pharmacist's review of the efficacy and safety of semaglutide in a population of type-2 diabetic Native Americans at a rural Indian Health Service facility
Favorite
3:30 PM – 5:00 PM
(1-279) Comparative Analysis of a Real-Time and an Intermittent-Scanning Continuous Glucose Monitoring System to Decrease A1C in a Rural Native American Population
Favorite
3:30 PM – 5:00 PM
(1-280) Pharmacist Evaluation and Discontinuation of Inappropriate Aspirin Therapy in Elderly Patients Prescribed Direct Oral Anticoagulants
Favorite
3:30 PM – 5:00 PM
(1-281) Utilization of Vancomycin: Pre and Post Implementation of MRSA Nasal Swabs in the Inpatient Setting
Favorite
3:30 PM – 5:00 PM
(1-282) Evaluation of a Pharmacist-Ran Tobacco Cessation Clinic Quit Rate Before and After Varenicline Recall
Favorite
3:30 PM – 5:00 PM
(1-283) Pharmacist Interventions in Patients with COPD Utilizing the COPD Dashboard at the Oklahoma City Veterans Affairs Health Care System: A Quality Improvement Project
Favorite
3:30 PM – 5:00 PM
(1-284) Describe the Management of Heart Failure with Reduced Ejection Fraction Post Hospitalization at the Oklahoma City Veterans Health Care System
Favorite
3:30 PM – 5:00 PM
(1-285) Assessment of Long-Term Success Rates at a Pharmacist-Run Tobacco Cessation Clinic Over a 10-Year Period.
Favorite
3:30 PM – 5:00 PM
(1-286) Utility of a Clinical Pharmacist Practitioner in the Deprescribing of Z-hypnotics in Older Adults
Favorite
3:30 PM – 5:00 PM
(1-287) Implementation of an Emergency Contraception Standard Operating Procedure (SOP) for Outpatient Pharmacists at the Roseburg VA Health Care System (RVAHCS)
Favorite
3:30 PM – 5:00 PM
(1-288) Evaluating the Occurrence of Mania-Related Hospitalizations in Patients with Bipolar Disorder or Schizoaffective Disorder Receiving Antidepressant Therapy
Favorite
3:30 PM – 5:00 PM
(1-289) Evaluating prescribing practices by oncology healthcare trainees for the treatment of cancer pain
Favorite
3:30 PM – 5:00 PM
(1-290) Implementation of Targeted Educational Intervention for Inappropriate Treatment of Asymptomatic Bacteriuria in Outpatient Veterans
Favorite
3:30 PM – 5:00 PM
(1-291) Establishing Monitoring Standards for Medication Therapy for Adults with Attention Deficient Hyperactivity Disorder (ADHD)
Favorite
3:30 PM – 5:00 PM
(1-292) Magnesium in Atrial Fibrillation: a Retrospective Review Evaluating Safety and Efficacy of Intravenous Magnesium for Attainment of Rate and Rhythm Control
Favorite
3:30 PM – 5:00 PM
(1-293) Evaluating the impact of interventions for warfarin-treated Veterans with low time-in-therapeutic range (TTR) in a pharmacist-led anticoagulation clinic within a Veteran Affairs Health Care System
Favorite
3:30 PM – 5:00 PM
(1-294) Evaluating the Impact of Standardizing Documentation for Psychotropic Long-Acting injectable (LAI) Administration on Current Nursing Practice at a Veterans' Affairs Hospital
Favorite
3:30 PM – 5:00 PM
(1-295) Impact of Clinical Pharmacist Interventions on Potentially Overbasalized Insulin Patients
Favorite
3:30 PM – 5:00 PM
(1-296) Understanding Stable Doses of Buprenorphine for Use in Chronic Pain
Favorite
3:30 PM – 5:00 PM
(1-297) Empowering Veterans to Deprescribe Antipsychotics and Gabapentinoids
Favorite
3:30 PM – 5:00 PM
(1-298) Evaluation of Current Practices Regarding Sexually Transmitted Infection Screenings and Empiric Therapy in the Emergency Department
Favorite
3:30 PM – 5:00 PM
(1-300) Implementation of an Oral Chemotherapy Adherence Program in Patients with Prostate Cancer at a Rural Veterans Affairs Hospital
Favorite
3:30 PM – 5:00 PM
(1-301) Evaluation of Basic Metabolic Panel Lab Monitoring after Initiation of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
Favorite
3:30 PM – 5:00 PM
(1-302) Implementation of Pharmacogenomic Testing to Evaluate the Efficacy of Clopidogrel in Patients Post Percutaneous Coronary Intervention (PCI)
Favorite
3:30 PM – 5:00 PM
(1-303) Implementation of Buprenorphine as Medication for Addiction Treatment (MAT) in the Emergency Department (ED) at the Lebanon Veteran Affairs Medical Center (LVAMC)
Favorite
3:30 PM – 5:00 PM
(1-304) Implementing a Pharmacist-Led Deprescribing Program to Reduce the Improper Use of Gabapentinoids
Favorite
3:30 PM – 5:00 PM
(1-305) Implementation of an Invasive Fungal Infection Prophylaxis Protocol for Liver Transplant Recipients
Favorite
3:30 PM – 5:00 PM
(1-306) Clinical Pharmacist Practitioner Led Pharmacogenomic Pilot Program within Home-Based Primary Care
Favorite
3:30 PM – 5:00 PM
(1-307) Evaluation of Clindamycin Outpatient Prescribing at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-308) Assessing Sodium Monitoring Standards for Caribbean Health Care System Geriatric Veterans: Prevalence of Iatrogenic Syndrome of Inappropriate Antidiuretic Hormone and Hyponatremia with Beers Criteria Medications
Favorite
3:30 PM – 5:00 PM
(1-309) Access to Oral Emergency Contraception at the Veterans Affairs Caribbean Healthcare System (VACHS)
Favorite
3:30 PM – 5:00 PM
(1-310) Determining Risk Factors for Pseudomonas Aeruginosa Infection in Adult Veterans Diagnosed with Urinary Tract Infections at the VA Caribbean Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-311) To Prescribe or Deprescribe: Antiplatelet Discontinuation versus Proton Pump Inhibitor (PPI) Addition in Veterans with Combined Antithrombotic Therapy
Favorite
3:30 PM – 5:00 PM
(1-313) Evaluation of Semaglutide 1 mg Injection versus Semaglutide 2 mg Injection in the Management of Type 2 Diabetes Mellitus: A Cost versus Health Benefit Analysis
Favorite
3:30 PM – 5:00 PM
(1-314) Medication Use Evaluation of Cholinesterase Inhibitors and Memantine in Home Based Primary Care
Favorite
3:30 PM – 5:00 PM
(1-315) Evaluation of Electrocardiogram Monitoring Among Veterans Prescribed High Doses of Citalopram or Escitalopram
Favorite
3:30 PM – 5:00 PM
(1-316) Evaluation of Insulin Glargine-yfgn in Veterans for the Treatment of Type II Diabetes Mellitus at the Providence Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-317) Implementation of a Surgical Antibiotic Prophylaxis Order Set at the Columbia VA Medical Center: A Quality Improvement Initiative
Favorite
3:30 PM – 5:00 PM
(1-318) Implementation of Gout Guideline Directed Medical Therapy with Allopurinol Optimization Based on Uric Acid Levels in a Veterans Affairs Ambulatory Care Outpatient Clinic
Favorite
3:30 PM – 5:00 PM
(1-319) Impact of an Inpatient Heart Failure Decision Support Tool on Guideline Directed Medical Therapy Prescribing Patterns
Favorite
3:30 PM – 5:00 PM
(1-320) Naloxone Prescribing Patterns in a Veterans Affairs Emergency Department
Favorite
3:30 PM – 5:00 PM
(1-321) Utilization of Population Health Dashboards to Improve Cardiology Medication Monitoring in a Rural Veterans Affairs Health Care System
Favorite
3:30 PM – 5:00 PM
(1-322) Outcomes of an Initiative to Decrease Non-steroidal Anti-inflammatory Use Among Outpatient Veterans Taking Direct Oral Anticoagulants
Favorite
3:30 PM – 5:00 PM
(1-323) Outcomes of Pharmacist-Led Effort to Improve Naloxone Education and Distribution via Alternative Means
Favorite
3:30 PM – 5:00 PM
(1-324) Developing and Implementing Pharmacist Initiated Treatment for Acute Infections
Favorite
3:30 PM – 5:00 PM
(1-325) Pharmacist-Led Initiative to Improve Glycemic Control Therapies in Veterans
Favorite
3:30 PM – 5:00 PM
(1-326) The Impact of Implementation of a Population Dashboard Tool on Pharmacogenomic Interventions in a High-Risk Veteran Patient Population
Favorite
3:30 PM – 5:00 PM
(1-327) Impact of switching antiplatelet therapy to treat stroke in African American patients already on aspirin
Favorite
3:30 PM – 5:00 PM
(1-328) Impact of Obesity on Heart Failure Hospitalization in Veterans on Sacubitril/Valsartan
Favorite
3:30 PM – 5:00 PM
(1-329) Outcomes of Pharmacist Utilization of Population Health Management Tools to Identify and Treat Patients with Uncontrolled Hypertension
Favorite
3:30 PM – 5:00 PM
(1-330) Impact of Race on Heart Failure Admissions in Veterans on Sacubitril/Valsartan
Favorite
3:30 PM – 5:00 PM
(1-331) Efficacy and Safety of Daptomycin Dosing Using Adjusted Body Weight in Obese Veterans
Favorite
3:30 PM – 5:00 PM
(1-332) Outcomes of Pharmacist-led Tobacco Cessation Clinic in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-333) Combination Opioid and Benzodiazepine Deprescribing Following Implementation of a Pharmacist-Led Risk Review at a VA Hospital
Favorite
3:30 PM – 5:00 PM
(1-334) Turning the Corner - Utilization of Letermovir for Cytomegalovirus Prophylaxis in Allogeneic Stem Cell Transplant in the Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-335) Outcomes of Medications for Alcohol Use Disorder in Veterans with Concurrent Opioid Use Disorder on Buprenorphine
Favorite
3:30 PM – 5:00 PM
(1-336) Suicide-Related Events when using Glucagon Like Peptide 1 Receptor Agonists in a Veteran Population with a History of Mental Health Conditions
Favorite
3:30 PM – 5:00 PM
(1-337) Impact of Completed Transitions of Care Consults on 30-Day Readmission Rates in Veterans with an Ambulatory Care Sensitive Condition
Favorite
3:30 PM – 5:00 PM
(1-338) Factors Contributing to Hypoglycemia in Patients with Diabetes on a GLP-1 Receptor Agonist
Favorite
3:30 PM – 5:00 PM
(1-339) Current Mineralocorticoid Receptor Antagonist (MRA) Use Practices in Patients with Chronic Kidney Disease (CKD) Stages 3-5 Within the Central Texas Veterans Health Care System
Favorite
3:30 PM – 5:00 PM
(1-340) The Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Decolonization Attempts
Favorite
3:30 PM – 5:00 PM
(1-341) An Educational Series on Hypertension Provided by a Pharmacist to Primary Care Teams to Improve Blood Pressure Control in Veterans with Uncontrolled Hypertension
Favorite
3:30 PM – 5:00 PM
(1-342) Evaluation of Completion of Routine Abnormal Involuntary Movement Score (AIMS) Monitoring in Patients Receiving Vesicular Monoamine Transporter 2 (VMAT-2) Inhibitors
Favorite
3:30 PM – 5:00 PM
(1-343) Safety Evaluation of Direct Oral Anticoagulants vs. Warfarin in Veterans with Cirrhosis
Favorite
3:30 PM – 5:00 PM
(1-344) Semaglutide Plus Metformin vs. Metformin Alone for Antipsychotic-Induced Weight Gain in Patients With Type 2 Diabetes Mellitus
Favorite
3:30 PM – 5:00 PM
(1-345) Implementation of a Penicillin Allergy De-Labeling Algorithm at a Large Veteran Affairs Medical Center Infectious Disease Clinic
Favorite
3:30 PM – 5:00 PM
(1-346) Evaluation of Appropriate Z-Drug Prescribing Before and After Pharmacist Led Education
Favorite
3:30 PM – 5:00 PM
(1-347) Implementation of the Hypoglycemic Safety Initiative at a Veterans Affairs Community Based Outpatient Clinic
Favorite
3:30 PM – 5:00 PM
(1-348) Implementation of a Transitions of Care (TOC) Pharmacy Service in an Outpatient Based Veterans Affairs Healthcare Facility
Favorite
3:30 PM – 5:00 PM
(1-349) Impact of Current Induction Therapy Protocol on Infection, Malignancy, and Rejection Episodes in Veteran Heart Transplant Recipients
Favorite
3:30 PM – 5:00 PM
(1-350) Evaluation of Buprenorphine Induction Techniques Within an Anesthesia Chronic Pain Clinic
Favorite
3:30 PM – 5:00 PM
(1-351) Development of an Equity-Focused Assessment Template Addressing Disparities of Blood Pressure Control for Black Veterans within the Salt Lake City VA Health Care System (SLCVAHCS)
Favorite
3:30 PM – 5:00 PM
(1-352) Assessment of Ordering and Education Practices for New Continuous Glucose Monitor (CGM) Starts by Pharmacists at VA Salt Lake City Healthcare System (VASLCHCS)
Favorite
3:30 PM – 5:00 PM
(1-353) The Impact of VA Clinical Pharmacist Intervention on the Continuation of Nicotine Replacement Therapies and Tobacco Cessation Rates Post-Discharge
Favorite
3:30 PM – 5:00 PM
(1-354) Evaluating the Appropriateness of Prophylactic Antibiotic Use Prior to Dental Procedure at a Rural Veteran Hospital
Favorite
3:30 PM – 5:00 PM
(1-355) Inappropriate Use of Intravenous Antibiotics in Patients Hospitalized for Heart Failure Without Evidence of Infection at a Single Center VA Hospital
Favorite
3:30 PM – 5:00 PM
(1-356) Evaluating vancomycin trough-based dosing and monitoring with Bayesian calculator estimated AUC/MIC values in a level II trauma Military Medical Treatment Facility
Favorite
3:30 PM – 5:00 PM
(1-357) HLA-B*5801 Testing for Allopurinol Initiation in High-Risk Patients in the Primary Care Setting
Favorite
3:30 PM – 5:00 PM
(1-358) Pharmacy Involvement in Outpatient Spinal Cord Injury Annual Evaluation
Favorite
3:30 PM – 5:00 PM
(1-359) VA Puget Sound Staffing Model: A Time-and-Motion and Workload Study
Favorite
3:30 PM – 5:00 PM
(1-360) Age Friendly Inpatient Medication Reconciliation in Spinal Cord Injury Veterans
Favorite
3:30 PM – 5:00 PM
(1-361) Creation and utilization of Medication Renewal Dashboard to increase compliance to renewal criteria for Semaglutide weight loss
Favorite
3:30 PM – 5:00 PM
(1-363) Improving Inhaler Technique Among Native Americans in an IHS Outpatient Clinic With the Aid of an Aerosol Inhalation Monitor
Favorite
3:30 PM – 5:00 PM
(1-364) Efficacy of GLP-1 receptor agonist therapy in achieving weight loss over 3, 6, and 12 months in veterans
Favorite
3:30 PM – 5:00 PM
(1-365) Effect of Levalbuterol on Heart Rate at a Level II Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-366) Retrospective analysis of angiotensin receptor-neprilysin inhibitor compared to angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and effect on hospitalizations in patients with heart failure
Favorite
3:30 PM – 5:00 PM
(1-367) Impact of Pharmacist Led Provider Education on Pharmacogenomic Testing for Veterans (PHASER) Ordering
Favorite
3:30 PM – 5:00 PM
(1-368) Retrospective Analysis of A1C Changes and Safety Outcomes in Veterans Transitioned to Continuous Glucose Monitoring From Self-monitoring
Favorite
3:30 PM – 5:00 PM
(1-369) Improve access to medications for alcohol use disorder within primary care
Favorite
3:30 PM – 5:00 PM
(1-370) Comparing Re-occurrence of Pneumonia Within One Year in Chronic Obstructive Pulmonary Disease Patients on Inhaled Corticosteroids Versus Patients With Discontinued Inhaled Corticosteroids
Favorite
3:30 PM – 5:00 PM
(1-371) Inpatient Medication Reconciliation: Retrospective Review of Current Process
Favorite
3:30 PM – 5:00 PM
(1-372) Impact of Clinical Pharmacist Practitioner Offer of Lung Cancer Screening in a VA Tobacco Treatment Clinic
Favorite
3:30 PM – 5:00 PM
(1-373) A Proactive Population Management Approach to Identify and Address Health Disparities and Increase Minority Veteran Access to Care
Favorite
3:30 PM – 5:00 PM
(1-374) Standardized Clinical Evaluation of Controlled Substance Co-prescriptions at a Veterans Affairs Hospital
Favorite
3:30 PM – 5:00 PM
(1-375) Evaluating the Impact of Enhanced Integration of Clinical Pharmacist Practitioners in Patient Aligned Care Teams
Favorite
3:30 PM – 5:00 PM
(1-376) Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State Treatment: Standardizing a High Risk and Low Volume Condition at the Cheyenne VA Medical Center (VAMC)
Favorite
3:30 PM – 5:00 PM
(1-377) Controlled Substance Ordering Note: Opioid Risk Mitigation Compliance at the Cheyenne VA Health Care System
Favorite
3:30 PM – 5:00 PM
(1-378) Cardiovascular Risk Reduction Using Statins in Patients with Type 2 Diabetes Mellitus at a Rural Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-379) Impact of a clinical pharmacist on the appropriateness of prescription stimulant monitoring
Favorite
3:30 PM – 5:00 PM
(1-380) Classifying Medication Reconciliation Discrepancies and Engaging in Pharmacy-mediated Medication Reviews at Hospital Admission
Favorite
